Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-03-03
1997-04-22
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
056229593
ABSTRACT:
The present invention is directed to the use of pharmaceutical compositions, containing an effective amount of topoisomerase I inhibitor such as camptothecin, useful in blocking both the initiation of infection and replication of retroviruses in host cells, thus reducing and eliminating retroviral production in infected cells. Use of such inhibitors provides as means of reducing or eliminating retroviral infections and their deleterious consequences in infected humans and animals.
REFERENCES:
Civitico et al 113 CA:144906z 1990.
Snapka, 1986, Molecular & Cellular Biology, Dec. 1986 pp. 4221-4227.
Civitico et al, Journal of Medicinal Virology, 31:90-97 (1990).
Yanagida et al, Nucleic Acids and Molecular Biology, 1:196-209 (1987).
Grandgenett et al, Cell, 60:3-4 (Jan. 12, 1990).
Brown et al, Cell, vol. 49, pp. 347-356 (May 8, 1987).
Brown et al, Proc. Natl. Acad. Sci. USA, vol. 86, pp. 2525-2529 (Apr. 1989).
Fujiwara et al, Proc. Natl. Acad. Sci. USA, vol. 86, pp. 3065-3069 (May 1989).
Weiss et al, Cold Spring Harbor Laboratory, pp. 392-393 (1982).
Temin et al, Advances in Viral Research, vol. 17, pp. 129-155 (1972).
Schreiber et al, Chemical Abstracts, 110:57987w (1989).
Giovanella et al, Science, vol. 246, pp. 1046-1048 (1989).
Foglesong, Chemical Abstracts, 95:56996h (1981).
Liu et al, Chemical Abstracts, 93:2764w (1980).
Civitico et al, Chemical Abstracts, 113:144906z (1990).
Hutchinson, Tetrahedron, vol. 37, pp. 1047-1065 (1981).
Lock et al, Anti-Cancer Drug Design, vol. 2, pp. 151-164 (1987).
Mitsuya et al, PNAS, vol. 82, pp. 7096-7100 (Oct. 1985).
Priel et al, Abstracts of the Fifth International Conference on AIDS, p. 586 (1989).
Snapka, Mol. and Cellular Biology, pp. 4221-4227 (Dec. 1986).
Stewart et al, Cell, vol. 60, pp. 141-149 (Jan. 12, 1990).
Wall et al, J. of the Amer. Chem. Soc., vol. 88, pp. 3888-3890 (Aug. 20, 1966).
Weis et al, Virology, vol. 114, pp. 563-566 (1981).
Blair Donald G.
Priel Esther
Showalter Stephen D.
The United States of America as represented by the Department of
Travers Russell
LandOfFree
Method of treating retroviral infections in mammals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating retroviral infections in mammals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating retroviral infections in mammals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-341832